XML 29 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTRICTED STOCK (Details Narrative 1) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Stock Options And Restricted Stock    
Aggregate restricted shares of Common Stock pursuant to 2008 plan 64,088  
Fair Value of restricted stock $ 313,000  
Share-based compensation expense 355,000 200,000
Shares of non-vested restricted stock 322,590  
Total unrecognized compensation expense $ 863,000  
FDA Approval [Member]
   
Stock Options And Restricted Stock    
Restricted stock to vest upon FDA approval 165,460  
Yearly [Member]
   
Stock Options And Restricted Stock    
Restricted stock to vest upon FDA approval 157,130